BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 16310504)

  • 41. Subretinal fibrosis and choroidal neovascularization in Vogt-Koyanagi-Harada syndrome.
    Lertsumitkul S; Whitcup SM; Nussenblatt RB; Chan CC
    Graefes Arch Clin Exp Ophthalmol; 1999 Dec; 237(12):1039-45. PubMed ID: 10654175
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The prognostic value of angiography in Vogt-Koyanagi-Harada disease.
    Chee SP; Jap A; Cheung CM
    Am J Ophthalmol; 2010 Dec; 150(6):888-93. PubMed ID: 20933219
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DETECTION OF CHOROIDAL FOLDS IN PATIENTS WITH VOGT-KOYANAGI-HARADA DISEASE BY RETROMODE SCANNING LASER OPHTHALMOSCOPY.
    Kinoshita T; Imaizumi H; Miyamoto H; Katome T; Mitamura Y
    Retin Cases Brief Rep; 2016; 10(2):160-4. PubMed ID: 26444520
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical study of Vogt-Koyanagi-Harada syndrome (author's transl)].
    Kawata K
    Fukuoka Igaku Zasshi; 1978 Nov; 69(11):473-85. PubMed ID: 738693
    [No Abstract]   [Full Text] [Related]  

  • 45. Ocular brucellosis vs Vogt-Koyanagi-Harada syndrome.
    Goldstein DA; Tessler HH
    Arch Ophthalmol; 2006 Apr; 124(4):608-9; author reply 609. PubMed ID: 16606901
    [No Abstract]   [Full Text] [Related]  

  • 46. Vogt-Koyanagi-Harada syndrome in children: report of a case and review of the literature.
    Berker N; Ozdamar Y; Soykan E; Ozdal P; Ozkan SS
    Ocul Immunol Inflamm; 2007; 15(4):351-7. PubMed ID: 17763135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Choroidal thickness in eyes with posterior recurrence of Vogt-Koyanagi-Harada disease after high-dose steroid therapy.
    Hashizume K; Imamura Y; Fujiwara T; Machida S; Ishida M; Kurosaka D
    Acta Ophthalmol; 2014 Sep; 92(6):e490-1. PubMed ID: 24588838
    [No Abstract]   [Full Text] [Related]  

  • 48. Serous Macular Detachment in Probable Vogt-Koyanagi-Harada Syndrome.
    Li AS; Tang PH; Do DV
    JAMA Ophthalmol; 2020 May; 138(5):e191981. PubMed ID: 32407448
    [No Abstract]   [Full Text] [Related]  

  • 49. Triple agent immunosuppressive therapy in Vogt-Koyanagi-Harada syndrome.
    Agarwal M; Ganesh SK; Biswas J
    Ocul Immunol Inflamm; 2006 Dec; 14(6):333-9. PubMed ID: 17162603
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A case of insulin dependent diabetes mellitus following systemic treatment for Vogt-Koyanagi-Harada syndrome.
    Maruyama Y; Hayashi H; Takahashi K; Iino K; Kora Y
    Ophthalmic Surg Lasers; 2000; 31(6):487-90. PubMed ID: 11095127
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Vogt Koyanagi Harada syndrome. Report of a case with hearing loss, tinnitus, vertigo associated to uveitis].
    Pino Rivero V; Pardo Romero G; Rodríguez Carmona M; Iglesias González RJ; del Castillo Beneyto F
    An Otorrinolaringol Ibero Am; 2007; 34(3):281-5. PubMed ID: 17725172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Vogt-Koyanagi-Harada disease complicated by subretinal neovessels].
    Lepvrier-Guibal N; Korobelnik JF; Xuan TH
    J Fr Ophtalmol; 1995; 18(4):305-11. PubMed ID: 7769166
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Typical smokestack leak sign in a case of Vogt-Koyanagi-Harada disease.
    Rani PK; Chandra P
    Ocul Immunol Inflamm; 2014 Aug; 22(4):341-4. PubMed ID: 24564503
    [No Abstract]   [Full Text] [Related]  

  • 54. Vogt-Koyanagi-Harada disease in the developing world.
    Concha del Río LE; Arellanes-García L
    Int Ophthalmol Clin; 2010; 50(2):189-99. PubMed ID: 20375871
    [No Abstract]   [Full Text] [Related]  

  • 55. An association between Vogt-Koyanagi-Harada disease and Guillain-Barré syndrome.
    Najman-Vainer J; Levinson RD; Graves MC; Nguyen BT; Engstrom RE; Holland GN
    Am J Ophthalmol; 2001 May; 131(5):615-9. PubMed ID: 11336936
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of pulse steroid treatment of ten days' long on the improvement of bacillary layer detachment in a patient with Vogt-Koyanagi Harada disease.
    Atas F; Kaya M; Saatci AO
    Rom J Ophthalmol; 2021; 65(2):183-186. PubMed ID: 34179585
    [No Abstract]   [Full Text] [Related]  

  • 57. Case report: Vogt-Koyanagi-Harada disease in an African-American female.
    Qutub ON; Halder RM
    J Drugs Dermatol; 2012 Aug; 11(8):1004-5. PubMed ID: 22859250
    [No Abstract]   [Full Text] [Related]  

  • 58. Vogt-Koyanagi-Harada syndrome in two patients with immunoglobulin A nephropathy.
    Matsuo T; Masuda I; Ota K; Yamadori I; Sunami R; Nose S
    Acta Med Okayama; 2007 Oct; 61(5):305-9. PubMed ID: 17971847
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated choroidal blood flow velocity during systemic corticosteroid therapy in Vogt-Koyanagi-Harada disease.
    Hirose S; Saito W; Yoshida K; Saito M; Dong Z; Namba K; Satoh H; Ohno S
    Acta Ophthalmol; 2008 Dec; 86(8):902-7. PubMed ID: 19016661
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anterior segment optical coherence tomography findings of acute angle-closure glaucoma in Vogt-Koyanagi-Harada disease.
    Yamamura K; Mori K; Hieda O; Kinoshita S
    Jpn J Ophthalmol; 2008; 52(3):231-232. PubMed ID: 18661276
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.